IL245496D0
|
|
Compounds for the treatment of diabetes and disease complications arising from same
|
IL240414D0
|
|
Device and methodology for measuring minute changes in ambient magnetic field
|
IL237446D0
|
|
Diagnostic agents with enhanced sensitivity/specificity
|
WO2015068156A1
|
|
Compounds for the treatment of diabetes and disease complications arising from same
|
IL231330D0
|
|
Methods for diagnosing cancer
|
WO2014122644A1
|
|
Device and methodology for measuring minute changes in ambient magnetic field
|
WO2014072969A1
|
|
Gold nanostructures and processes for their preparation
|
IL228463D0
|
|
Coatings for solar applications
|
EP2895202A1
|
|
Diagnostic agents with enhanced sensitivity/specificity
|
WO2014041538A1
|
|
Method and system for designing a common end effector for a robot which is capable of grasping plurality of parts, each having its own geometry
|
WO2014041536A1
|
|
Integrated circuit with photonic elements
|
WO2014045274A1
|
|
Bilayer graphene diode
|
WO2014030162A1
|
|
Separating clinically relevant sources of electrical activity in ecg signals
|
WO2014024163A2
|
|
Coherent field gradient momentum splitting
|
WO2014024184A1
|
|
A high efficiency resonant switched capacitor converter with continuous conversion ratio
|
IL227304D0
|
|
A method for evaluating a mental disorder
|
US2013285008A1
|
|
Nanowires, method of fabrication the same and uses thereof
|
WO2013183048A1
|
|
Functionalized titanium binding peptides and implants coated with same
|
US2015119741A1
|
|
Apparatus and method for diagnosing sleep quality
|
EP2841875A1
|
|
True-spectroscopic dual mode high resolution full-field optical coherence tomography using liquid crystal devices
|